Related Experiment Videos
Factual reflections and recommendations on extracorporeal photopheresis in pediatrics
Irena Sniecinski1, Jerard Seghatchian2
1Retired Director Department of Transfusion Medicine and retired member-physician, Division of Hematology and BMT, City of Hope National Research Institute, Duarte, CA, USA .
Insights
Extracorporporeal photopheresis (ECP) in pediatric patients, especially those with graft-versus-host disease (GVHD), presents challenges due to varied practices. This review focuses on safety considerations for long-term ECP in low-weight children.
Area of Science:
- Pediatric Hematology
- Transfusion Medicine
- Immunology
Background:
- Extracorporeal photopheresis (ECP) is utilized in pediatric patients, particularly for graft-versus-host disease (GVHD) post-hematopoietic stem cell transplantation.
- Existing literature on pediatric ECP exhibits significant heterogeneity in patient evaluation, procedural techniques, and apheresis product analysis.
- GVHD management in children necessitates careful consideration due to their rapidly changing clinical status.
Purpose of the Study:
- To review safety issues associated with long-term extracorporporeal photopheresis (ECP) in low-weight pediatric patients.
- To highlight the challenges posed by heterogeneous ECP practices in pediatric care.
- To emphasize the need for careful patient assessment and monitoring during ECP therapy.
Main Methods:
- Literature review focusing on safety aspects of ECP in pediatric populations.
- Analysis of approaches to patient evaluation and procedural considerations.
- Examination of apheresis product analysis in the context of pediatric ECP.
Main Results:
- ECP in pediatric patients is generally considered safe, with limited adverse events reported in retrospective and observational studies.
- Heterogeneity in ECP practices complicates consistent evaluation and management.
- Close monitoring for hemodynamic compromise, hematologic, and metabolic disturbances is crucial.
Conclusions:
- Despite general safety, careful patient selection and vigilant monitoring are essential for pediatric ECP, especially in low-weight children.
- Addressing practice heterogeneity is key to optimizing ECP outcomes in pediatric GVHD.
- Specialized attention from transfusion medicine and pediatric specialists is required for safe long-term ECP therapy.
Abstract:
One of the biggest challenges in evaluating available literature on extracorporeal photopheresis (ECP) practices in pediatric patients is the marked heterogeneity of approaches to the patient evaluation, procedural aspects and apheresis product analysis. These issues are most relevant in ECP management in children with graft versus host disease (GVHD) after hematopoietic stem cell transplantation. Extracorporeal photopheresis in pediatric patients is considered relatively safe with few adverse effects reported from retrospective or observational studies. Careful patient eligibility assessment for ECP procedures and close monitoring while on ECP therapy is still required by transfusion medicine and pediatric specialists. Particular attention is necessary considering the rapidly changing clinical status of children with graft versus host disease after hematopoietic stem cell transplantation, focusing on hemodynamic compromise, hematologic and metabolic disturbances. This is a review of the approaches to some of the safety issues in long-term ECP therapy in low-weight pediatric patients.